181 related articles for article (PubMed ID: 16930497)
1. Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.
Thomas CA; Chuang YC; Giannantoni A; Chancellor MB
Curr Urol Rep; 2006 Jul; 7(4):266-71. PubMed ID: 16930497
[TBL] [Abstract][Full Text] [Related]
2. Botulinum-A toxin: an exciting new treatment option for prostatic disease.
Thomas CA; Guercini F; Chuang YC; Chancellor MB
Int J Clin Pract Suppl; 2006 Dec; (151):33-7. PubMed ID: 17169009
[TBL] [Abstract][Full Text] [Related]
3. The potential and promise of using botulinum toxin in the prostate gland.
Chuang YC; Giannantoni A; Chancellor MB
BJU Int; 2006 Jul; 98(1):28-32. PubMed ID: 16831138
[TBL] [Abstract][Full Text] [Related]
4. Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia-A Spotlight in Reality.
Hsu YC; Wang HJ; Chuang YC
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128942
[TBL] [Abstract][Full Text] [Related]
5. The application of botulinum toxin in the prostate.
Chuang YC; Chancellor MB
J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
[TBL] [Abstract][Full Text] [Related]
6. Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature.
Moore DC; Cohn JA; Dmochowski RR
Toxins (Basel); 2016 Mar; 8(4):88. PubMed ID: 27023601
[TBL] [Abstract][Full Text] [Related]
7. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Chiang BJ; Kuo HC; Liao CH
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
[TBL] [Abstract][Full Text] [Related]
8. Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trial.
Robert G; Descazeaud A; Karsenty G; Saussine C; Azzouzi AR; de la Taille A; Desgrandchamps F; Faix A; Fourmarier M; Georget A; Benard A; Barry Delongchamps N
World J Urol; 2018 Jun; 36(6):921-929. PubMed ID: 29383480
[TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin A for male lower urinary tract symptoms.
Chartier-Kastler E; Mehnert U; Denys P; Giuliano F
Curr Opin Urol; 2011 Jan; 21(1):13-21. PubMed ID: 21099691
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A in prostate disease: a venom from bench to bed-side.
Mearini L; Giannantoni A
Curr Drug Deliv; 2012 Jan; 9(1):85-94. PubMed ID: 22409179
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin in urology: a review of clinical potential in the treatment of urologic and sexual conditions.
Chung E
Expert Opin Biol Ther; 2015 Jan; 15(1):95-102. PubMed ID: 25347039
[TBL] [Abstract][Full Text] [Related]
12. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
[TBL] [Abstract][Full Text] [Related]
13. Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction.
Jhang JF; Kuo HC
Toxins (Basel); 2018 Jun; 10(7):. PubMed ID: 29949878
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin injection for lower urinary tract dysfunction.
Kuo YC; Kuo HC
Int J Urol; 2013 Jan; 20(1):40-55. PubMed ID: 22571329
[TBL] [Abstract][Full Text] [Related]
15. Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia.
Chuang YC; Chiang PH; Yoshimura N; De Miguel F; Chancellor MB
BJU Int; 2006 Nov; 98(5):1033-7; discussion 1337. PubMed ID: 16956361
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions.
Chancellor MB; Elovic E; Esquenazi A; Naumann M; Segal KR; Schiavo G; Smith CP; Ward AB
Toxicon; 2013 Jun; 67():129-40. PubMed ID: 23415704
[TBL] [Abstract][Full Text] [Related]
17. Intraprostatic botulinum toxin type A administration: evaluation of the effects on sexual function.
Silva J; Pinto R; Carvalho T; Botelho F; Silva P; Silva C; Cruz F; Dinis P
BJU Int; 2011 Jun; 107(12):1950-4. PubMed ID: 21105985
[TBL] [Abstract][Full Text] [Related]
18. The use of botulinum toxin in benign prostatic hyperplasia.
Marchal C; Perez JE; Herrera B; Machuca FJ; Redondo M
Neurourol Urodyn; 2012 Jan; 31(1):86-92. PubMed ID: 21905088
[TBL] [Abstract][Full Text] [Related]
19. The case for bladder botulinum toxin application.
Kim DK; Thomas CA; Smith C; Chancellor MB
Urol Clin North Am; 2006 Nov; 33(4):503-10, ix. PubMed ID: 17011386
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: randomized study comparing two doses.
Arnouk R; Suzuki Bellucci CH; Benatuil Stull R; de Bessa J; Malave CA; Mendes Gomes C
ScientificWorldJournal; 2012; 2012():463574. PubMed ID: 22997495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]